Hyaluronic acid-modified zirconium phosphate nanoparticles for potential lung cancer therapy

被引:11
作者
Li, Ranwei [2 ]
Liu, Tiecheng [3 ]
Wang, Ke [1 ]
机构
[1] Jilin Univ, Affiliated Hosp 2, Dept Resp Med, Changchun 130041, Jilin, Peoples R China
[2] Jilin Univ, Affiliated Hosp 2, Dept Urinary Surg, Changchun 130041, Jilin, Peoples R China
[3] Jilin Univ, Affiliated Hosp 2, Dept Anesthesiol, Changchun 130041, Jilin, Peoples R China
来源
BIOMEDICAL ENGINEERING-BIOMEDIZINISCHE TECHNIK | 2017年 / 62卷 / 01期
关键词
hyaluronic acid; lung cancer; paclitaxel; zirco-nium phosphate; NANO-SYSTEM; CO-DELIVERY; DRUG; MICELLES; GENE;
D O I
10.1515/bmt-2015-0238
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
Novel tumor-targeting zirconium phosphate (ZP) nanoparticles modified with hyaluronic acid (HA) were developed (HA-ZP), with the aim of combining the drug-loading property of ZP and the tumor-targeting ability of HA to construct a tumor-targeting paclitaxel (PTX) delivery system for potential lung cancer therapy. The experimental results indicated that PTX loading into the HA-ZP nanoparticles was as high as 20.36%+/- 4.37%, which is favorable for cancer therapy. PTX-loaded HA-ZP nanoparticles increased the accumulation of PTX in A549 lung cancer cells via HA-mediated endocytosis and exhibited superior anticancer activity in vitro. In vivo anticancer efficacy assay revealed that HA-ZP nanoparticles possessed preferable anticancer abilities, which exhibited minimized toxic side effects of PTX and strong tumor-suppression potential in clinical application.
引用
收藏
页码:67 / 73
页数:7
相关论文
共 50 条
[31]   Comparative study of dual delivery of gemcitabine and curcumin using CD44 targeting hyaluronic acid nanoparticles for cancer therapy [J].
Thummarati, Parichart ;
Suksiriworapong, Jiraphong ;
Sakchaisri, Krisada ;
Nawroth, Thomas ;
Langguth, Peter ;
Roongsawang, Benjamaporn ;
Junyaprasert, Varaporn Buraphacheep .
JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY, 2022, 77
[32]   Hypocrellin B and paclitaxel-encapsulated hyaluronic acid-ceramide nanoparticles for targeted photodynamic therapy in lung cancer [J].
Chang, Ji-Eun ;
Cho, Hyun-Jong ;
Yi, Eunjue ;
Kim, Dae-Duk ;
Jheon, Sanghoon .
JOURNAL OF PHOTOCHEMISTRY AND PHOTOBIOLOGY B-BIOLOGY, 2016, 158 :113-121
[33]   Hybride nanoparticles composed of SN38-modified [12]aneN3 and biotinylated lipids for targeted and synergistic lung Cancer therapy [J].
Xu, De-Zhong ;
Yang, Jing-Bo ;
Zhang, Xi ;
Ren, Zhi-Xuan ;
Liu, Rui ;
Tang, Quan ;
Lu, Zhong-Lin ;
Liu, Yang .
BIOORGANIC CHEMISTRY, 2025, 160
[34]   Lipid Nanoparticles in Lung Cancer Therapy [J].
Omidian, Hossein ;
Gill, Erma J. ;
Cubeddu, Luigi X. .
PHARMACEUTICS, 2024, 16 (05)
[35]   Folic acid-modified β-cyclodextrin nanoparticles as drug delivery to load DOX for liver cancer therapeutics [J].
Fan, Wenbo ;
Xu, Yuedi ;
Li, Zheng ;
Li, Qiang .
SOFT MATERIALS, 2019, 17 (04) :437-447
[36]   Glycyrrhetinic Acid-Modified Norcantharidin Nanoparticles for Active Targeted Therapy of Hepatocellular Carcinoma [J].
Zhang, Heng ;
Jiang, Yu ;
Ni, XiaoLing ;
Chen, LongXia ;
Wu, Min ;
Liu, Jing ;
Yang, Bo ;
Shan, Xu ;
Yang, LingLin ;
Fan, Juan ;
Chen, Yue ;
Wu, JingBo ;
Fu, ShaoZhi .
JOURNAL OF BIOMEDICAL NANOTECHNOLOGY, 2018, 14 (01) :114-126
[37]   Co-delivery of siRNA and hypericin into cancer cells by hyaluronic acid modified PLGA-PEI nanoparticles [J].
Li, Yanan ;
Zhang, Junling ;
Wang, Buhai ;
Shen, Yan ;
Ouahab, Ammar .
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 2016, 42 (05) :737-746
[38]   Hyaluronic Acid-Modified Micelles of Azithromycin and Quercetin Against Infections Caused by Methicillin-Resistant Staphylococcus Aureus [J].
Zhang, Zixu ;
Chen, Muhan ;
Wang, Jiahua ;
Liu, Mo ;
Guo, Ruibo ;
Zhang, Lu ;
Kong, Liang ;
Liu, Yang ;
Yu, Yang ;
Li, Xuetao .
INTERNATIONAL JOURNAL OF NANOMEDICINE, 2024, 19 :9637-9658
[39]   Hyaluronic acid-modified liposomal honokiol nanocarrier: Enhance anti-metastasis and antitumor efficacy against breast cancer [J].
Wang, Jing ;
Liu, Dan ;
Guan, Shuang ;
Zhu, Wenquan ;
Fan, Li ;
Zhang, Qi ;
Cai, Defu .
CARBOHYDRATE POLYMERS, 2020, 235
[40]   Folic acid-modified ginsenoside Rg5-loaded bovine serum albumin nanoparticles for targeted cancer therapy in vitro and in vivo [J].
Dong, Yanan ;
Fu, Rongzhan ;
Yang, Jing ;
Ma, Pei ;
Liang, Lihua ;
Mi, Yu ;
Fan, Daidi .
INTERNATIONAL JOURNAL OF NANOMEDICINE, 2019, 14 :6971-6988